McKesson Redefines Healing: Advanced Wound Portfolio Expands into Homecare
Published: 27 Mar 2026
Author: Precedence Research
McKesson Corporation has announced a major expansion of its wound care product line, focusing on B2B distribution and homecare uses, thus positioning itself as a leader in chronic wound management. This is especially important now due to the growing aging population and the increasing rates of diabetes in the DACH regions, creating a pressing demand for effective solutions. Investors are paying attention, as these products leverage McKesson's vast distribution network to access the growing healthcare supply market.
McKesson Accelerates Growth with Innovative Bioactive Wound Care Line
On March 17, 2026, McKesson introduced its next-generation wound care portfolio. This new range includes advanced bioactive dressings, negative pressure therapy devices, and digital monitoring kits tailored for B2B hospital suppliers and direct homecare delivery.
According to Precedence Research, the Wound Assessment Market size accounted for USD 1.84 billion in 2025 and is predicted to increase from USD 2.09 billion in 2026 to approximately USD 6.53 billion by 2035, expanding at a CAGR of 13.50% from 2026 to 2035 as demand grows with rising prevalence of chronic diseases such as diabetes and obesity causing non-healing ulcers, a rapidly aging population, and increased traumatic/surgical injuries.
Key products feature antimicrobial silver-infused foams that have shown a 25% decrease in infection rates during clinical trials. The homecare bundles include telehealth applications for remote wound evaluation, enabling nurses to monitor patient progress without needing in-person visits.
Driving Market Share: McKesson Unveils Advanced B2B and Home Care Solutions
This launch takes advantage of McKesson's established distribution capabilities, which support over 40,000 pharmacies and hospitals globally. The B2B segment focuses on securing bulk procurement contracts with wound care clinics, while homecare kits are sent directly to patients through partnered logistics.
The initial rollout will focus on high-need areas like Germany, Austria, and Switzerland, where chronic wounds affect over 2 million patients annually. The pricing for the advanced dressing kit starts at €45, which is 15% lower than competitors for bulk orders.
A recent report by Precedence Research highlights that the Wound Assessment Market is benefiting from the adoption of digital AI-powered tools for precise measurement and increased demand for advanced, faster-healing wound management solutions.